Multistate study examines mRNA vaccine effectiveness for immunocompromised adults during Omicron…
A new study from the Centers for Disease Control and Prevention's VISION Network presents and analyzes some of the first real-world data on mRNA COVID vaccine effectiveness during Omicron BA.4 and BA.5 predominance for immunocompromised…